首页|血清超敏CRP对抑郁症患者SNRI类药物治疗效果的影响研究

血清超敏CRP对抑郁症患者SNRI类药物治疗效果的影响研究

扫码查看
目的:探究血清超敏C反应蛋白(CRP)对抑郁症患者NE/5-HT再摄取抑制剂(SNRI)类药物治疗效果的影响.方法:回顾性分析我院2022 年 1 月—2023 年 1 月 64 例抑郁症患者的临床资料,检测血清超敏CRP水平,与同期40 例健康者的血清超敏CRP水平进行比较,分析超敏CRP在抑郁症患者中的诊断价值.所有患者均应用SNRI类药物治疗,依据治疗前血清超敏CRP水平将抑郁症患者分为低CRP组(<5mg/L)、高CRP组(≥5mg/L),比较两组患者的临床资料、治疗效果,使用KaplanMeier生存分析与Cox比例风险回归模型分析血清超敏CRP水平对SNRI类药物治疗中的作用.结果:抑郁症组患者治疗前血清超敏CRP水平高于健康组(P<0.05);抑郁症组患者治疗后血清超敏CRP水平与健康组比较无差异(P>0.05).抑郁症患者高CRP组与低CRP组性别、年龄、BMI指数、病程、病情程度比较,差异有统计学意义(P<0.05).抑郁症高CRP组用药时间高于低CRP组,治疗有效率低于低CRP组,差异有统计学意义(P<0.05).使用KaplanMeier生存分析,在SNRI类药物治疗中,高CRP组与低CRP组患者的治疗有效率有明显差异(χ2=4.837,P=0.038,df=1).经Cox比例风险回归模型分析,控制混杂因素后,低CRP组患者SNRI类药物的治疗有效率高于高CRP组(P<0.043,HR=1.291,95%CI:1.001~1.623),且病程是治疗效果的独立预测因素.结论:抑郁症患者的血清超敏CRP水平升高,而高超敏CRP水平会影响SNRI药物的治疗效果.
Effect of Serum Hypersensitive CRP on the Therapeutic Effect of SNRI Drugs in Patients with Depression
Objective:To explore the effect of serum high-sensitivity C-reactive protein(CRP)on the therapeutic effect of NE/5-HT reuptake inhibitors(SNRI)in patients with depression.Methods:The clinical data of 64 patients with depression in our hospital from January 2022 to January 2023 were retrospectively analyzed.The serum high-sensitivity CRP level was detected and compared with the serum high-sensitivity CRP level of 40 healthy people in the same period.The diagnostic value of high-sensitivity CRP in patients with depression was analyzed.All patients were treated with SNRI drugs.According to the level of serum high-sensitivity CRP before treatment,patients with depression were divided into low CRP group(<5 mg/L)and high CRP group(≥5 mg/L).The clinical data and therapeutic effects of the two groups were compared.Kaplan-Meier survival analysis and Cox proportional hazard regression model were used to analyze the effect of serum high-sensitivity CRP level on SNRI drug treatment.Results:The level of serum high-sensitivity CRP in the depression group was higher than that in the healthy group before treatment(P<0.05).There was no difference in serum hypersensitive CRP level between the depression group and the healthy group after treatment(P>0.05).There were significant differences in gender,age,BMI index,course of disease and degree of illness between the high CRP group and the low CRP group in patients with depression(P<0.05).The medication time of the depression high CRP group was higher than that of the low CRP group,and the effective rate of treatment was lower than that of the low CRP group,the differences were statistically significant(P<0.05).Kaplan-Meier survival analysis showed that there was a significant difference in the effective rate between the high CRP group and the low CRP group in the treatment of SNRI drugs(χ2=4.837,P=0.038,df=1).Cox proportional hazard regression model analysis showed that after controlling for confounding factors,the effective rate of SNRI drugs in the low CRP group was higher than that in the high CRP group(P<0.043,HR=1.291,95%CI:1.001-1.623),and the course of disease was an independent predictor of treatment effect.Conclusion:The level of serum hypersensitive CRP in patients with depression is increased,and the level of hypersensitive CRP will affect the therapeutic effect of SNRI drugs.

High-sensitivity C-reactive proteinDepressionNE/5-HT reuptake inhibitorsCurative effect

沙蕾、翁何霞

展开 >

南阳医学高等专科学校第一附属医院检验科,河南 南阳 473000

南阳医学高等专科学校药学系药学教研室,河南 南阳 473000

超敏C反应蛋白 抑郁症 NE/5-HT再摄取抑制剂 疗效

河南省科技厅科技攻关基金项目

152102310025

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.30(9)
  • 2